Vaccine. 2016 Jan 4;34(2):198-199. doi: 10.1016/j.vaccine.2014.07.068.
This article presents the World Health Organization's (WHO) recommendations for the use of varicella and herpes zoster vaccination from the WHO position paper on varicella and herpes zoster vaccines - June 2014, published in the Weekly Epidemiological Record [1]. This position paper summarizes the WHO position on the use of varicella and herpes zoster vaccines. The current document replaces the position paper on the use of varicella vaccines published in 1998 [2]. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2014 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html.
本文介绍了世界卫生组织（WHO）关于水痘和带状疱疹疫苗使用的建议，这些建议来自于2014年6月发表在《疫情周报》[1]上的WHO水痘和带状疱疹疫苗立场文件。该立场文件总结了WHO关于水痘和带状疱疹疫苗使用的立场。本文件取代了1998年发布的关于水痘疫苗使用的立场文件[2]。本文的脚注提供了一些核心参考文献。根据其向会员国提供卫生政策事项指导的任务，WHO发布了一系列定期更新的立场文件，内容涉及对具有国际公共卫生影响的疾病的疫苗及疫苗组合。这些文件主要关注疫苗在大规模免疫规划中的使用；它们总结了关于疾病和疫苗的基本背景信息，并以WHO在全球范围内使用疫苗的当前立场作为结论。本文反映了WHO免疫战略咨询专家组（SAGE）的建议。这些建议在SAGE 2014年4月的会议上进行了讨论。会议上展示的证据可在http://www.who.int/immunization/sage/previous/en/index.html查阅。
